AnPac Bio-Medical Science Co., Ltd.

NASDAQ:

ANPC

Anpac Bio is a biotechnology company focusing on early cancer screening, detection, and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.

Key Facts

Auditor

Public Listing

Domicile

HQ/Management

Location of Key Operations

IR Contact

Ernst & Young LLP

IPO (January 10, 2020)

British Virgin Islands

Lishui, Zhejiang, China

Tina Xiao, Ascent Investor Relations LLC

917-609-0333

Analyst Coverage

Latest News